TLR2 Activation Enhances Inflammatory Signaling and Accelerates Cyst Growth and Renal Fibrosis in Polycystic Kidney Disease Mice
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27093853 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Aiping Wei und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China. Hauptthemen laut MEDLINE: Toll-Like Receptor 2, Polycystic Kidney Diseases, Signal Transduction, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, The PKD Foundation, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Polycystic kidney disease (PKD), the most common inherited kidney disorder, is characterized by progressive cyst growth and eventual organ failure. Although aberrant innate immune activation is a recognized contributor to PKD progression, the underlying molecular mechanisms remain incompletely defined. Here, we showed that Pkd1 deletion increased TLR2 and MyD88 mRNA expression in renal epithelial cells, indicating enhanced innate immune priming. In vivo, administration of Pam3CSK4 (PAM), a synthetic TLR2 agonist, preferentially amplified pro-inflammatory and pro-fibrotic responses in Pkd1RC/RC mice compared with wild-type controls, despite inducing similar signaling responses in vitro. Acute PAM treatment for one week rapidly enhanced NF-κB activation in cyst-lining epithelial cells, increased renal inflammation and cell proliferation, and was associated with activation of mTOR signaling and upregulation of c-Myc and Wnt proteins. Sustained PAM treatment further accelerated cyst expansion and renal fibrosis in PKD mice. Importantly, the endogenous TLR2 ligands decorin and biglycan were markedly elevated in human PKD kidneys, supporting the translational relevance of enhanced TLR2 signaling in disease progression. Together, these findings suggest that TLR2 signaling is an important contributor to PKD progression and a potential therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China.
- Department of Biological Science, College of Sciences and Arts, Michigan Technological University, Houghton, MI 49931, USA.
ORCID-Profile: Jaden Schneider, Tyler Gregersen, Yong Li
Förderung
- NIDDK NIH HHS
- The PKD Foundation
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Wei, A., Zhang, Y., Xu, Y., Schneider, J., Detterman, N., Shu, X., Gregersen, T., Folch, M. N., Li, Y., Chen, S., & Zhang, Y. (2026). TLR2 Activation Enhances Inflammatory Signaling and Accelerates Cyst Growth and Renal Fibrosis in Polycystic Kidney Disease Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27093853
Vancouver
Wei A, Zhang Y, Xu Y, Schneider J, Detterman N, Shu X, et al. TLR2 Activation Enhances Inflammatory Signaling and Accelerates Cyst Growth and Renal Fibrosis in Polycystic Kidney Disease Mice. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27093853
BibTeX
@article{Wei2026,
author = {Wei, Aiping and Zhang, Yang and Xu, Yu and Schneider, Jaden and Detterman, Nicholas and Shu, Xiaoyun and Gregersen, Tyler and Folch, Maximo Nahas and Li, Yong and Chen, Shibiao and Zhang, Yan},
title = {TLR2 Activation Enhances Inflammatory Signaling and Accelerates Cyst Growth and Renal Fibrosis in Polycystic Kidney Disease Mice},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27093853}
}
EUVIMED